DEF 14A

Company

Anixa Biosciences Inc

Filed

July 5, 2016

Period of Report

August 23, 2016

Accession Number

0001513162-16-000906

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →